Affiliation:
1. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Abstract
ABSTRACT
Adult-onset Still’s disease is a systemic inflammatory disease characterized by high spiking fever, arthritis, evanescent skin rash, leukocytosis, and hyperferritinemia. The pathogenesis of adult-onset Still’s disease has not been fully understood yet; however, multiple proinflammatory cytokines, such as IL-1β and IL-6, play important roles in the development of adult-onset Still’s disease. IL-6 is a multifunctional cytokine that accelerates the differentiation of macrophages and cytotoxic T-cells and chemotaxis of neutrophils and macrophages. Serum concentrations of IL-6 well correlate with disease activity of adult-onset Still’s disease, and blockade of IL-6 has been proven to be effective in active adult-onset Still’s disease. This review will focus on the recent understanding of the role of proinflammatory cytokines of adult-onset Still’s disease and the efficacy of IL-6 inhibitors for the treatment of adult-onset Still’s disease.
Publisher
Oxford University Press (OUP)
Reference44 articles.
1. Mechanisms, biomarkers and targets for adult-onset Still’s disease;Feist;Nat Rev Rheumatol,2018
2. Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart;Jamilloux;Immunol Res,2015
3. Adult-onset Still’s disease-pathogenesis, clinical manifestations, and new treatment options;Kadavath;Ann Med,2015
4. Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial;Kaneko;Ann Rheum Dis,2018
5. Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan;Suematsu;Mod Rheumatol,2012
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献